PMC:3724972 / 31270-32016 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3724972","sourcedb":"PMC","sourceid":"3724972","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3724972","text":"The authors would like to thank Ken Scholz, PhD, Shirley McCartney, PhD, and David Wolff, MS, for editorial assistance with this manuscript.\n\nConflict of interest\nDr. Fleseriu has received consultant fees from Novartis Pharmaceuticals and Ipsen, and is a principal investigator in clinical trials sponsored by Novartis Pharmaceuticals, Corcept Therapeutics, and Ipsen, with research support to OHSU. Dr. Petersenn has received consultant fees from Novartis Pharmaceuticals, Pfizer and Ipsen, and is a principal investigator in clinical trials sponsored by Novartis Pharmaceuticals and Ipsen. Partial financial support (Ken Scholtz and David Wolff) has been provided by Novartis Pharmaceuticals. The authors are solely responsible for all content.","divisions":[{"label":"p","span":{"begin":0,"end":140}},{"label":"title","span":{"begin":142,"end":162}}],"tracks":[]}